Living with GVHD: A Transplant Patient Panel Discussion
Patient panel discussions are a chance to meet some of the inspiring patients, caregivers and parents who are dealing with a
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Patient panel discussions are a chance to meet some of the inspiring patients, caregivers and parents who are dealing with a
Cellular aging in hematopoietic cell transplantation (HCT) is important in the context of immune reconstitution and age-related complications. Recently, several DNA-methylation (DNAm)-based biomarkers of aging known as "epigenetic clocks" have been introduced as novel tools to predict cellular age.
Dr.
AAMDSIF is pleased to announce that we will host a support group for patients who have been treated with a transplant, or who are considering having a transplant. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants.
This virtual support group is to help support patients between the ages of 18-30 who have been diagnosed with
Dr. Shaffer is a board certified hematologist specializing in
The field of allogeneic stem cell transplantation continues to improve survival for patients with previously incurable blood cancers. However, up to 50% of patients who undergo transplantation with donor cells will develop chronic graft-vs-host disease, a potentially deadly condition that can also cause lifelong complications.
Dr. Niyongere joined the School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center as an Assistant Professor in 2018. Her clinical focus is in acute leukemias,
James R. Cook, M.D., Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine. He serves as Section Head of Hematopathology in the Department of Laboratory Medicine. Dr. Cook's clinical interests focus on diagnostic hematopathology and molecular diagnostics.
In this webinar, Dr. Saurabh Chhabra from The Cancer Center at Froedtert Hospital in Wisconsin will discuss the latest advances in preventing and treating graft-versus-host disease(GVHD). He will also provide a brief overview of GVHD.